We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current XBIO market cap is 5.82M. The company's latest EPS is USD -2.6839 and P/E is -1.41.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 414k | 487k | 606k | 651k | 611k |
| Operating Income | -848k | -1.56M | -915k | -1.2M | -1.15M |
| Net Income | -804k | -1.48M | -857k | -1.05M | -1.06M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 17k | 437k | 1.16M | 1.71M | 2.54M |
| Operating Income | -12.89M | -13.94M | -5.75M | -6.72M | -4.52M |
| Net Income | -18.06M | -10.89M | -5.65M | -6.55M | -4.14M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 15.57M | 14.72M | 13.72M | 12.75M | 11.96M |
| Total Liabilities | 1.05M | 1.07M | 856k | 871k | 1.07M |
| Total Equity | 14.52M | 13.65M | 12.86M | 11.88M | 10.89M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 21.55M | 13.18M | 19.82M | 14.72M | 10.61M |
| Total Liabilities | 4.33M | 963k | 1.42M | 1.07M | 809k |
| Total Equity | 17.21M | 12.22M | 18.39M | 13.65M | 9.8M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.9M | -4.65M | -1.1M | -2.37M | -3.32M |
| Investing | -500k | -500k | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -6.4M | -4.27M | -4.74M | -4.65M | -4.11M |
| Investing | 2k | N/A | N/A | -500k | N/A |
| Financing | 16.13M | 5.43M | 11.45M | N/A | N/A |
| Market Cap | 5.82M |
| Price to Earnings Ratio | -1.41 |
| Price to Sales Ratio | 2.29 |
| Price to Cash Ratio | 0.65 |
| Price to Book Ratio | 0.59 |
| Dividend Yield | - |
| Shares Outstanding | 1.54M |
| Average Volume (1 week) | 2.57k |
| Average Volume (1 Month) | 6.88k |
| 52 Week Change | -18.29% |
| 52 Week High | 5.97 |
| 52 Week Low | 2.55 |
| Spread (Intraday) | 0.75 (16.67%) |
| Company Name | Xenetic Biosciences Inc |
| Address |
3273 e warm springs road las vegas, nevada 89120 |
| Website | https://www.xeneticbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
